SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001753926-24-000328
Filing Date
2024-02-15
Accepted
2024-02-15 20:33:45
Documents
2
Period of Report
2024-02-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5750
2 POWER OF ATTORNEY g084039_ex24.htm EX-24 9642
  Complete submission text file 0001753926-24-000328.txt   17051
Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Issuer) CIK: 0001919246 (see all company filings)

IRS No.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 970 LAWRENCE AVENUE WEST SUITE 904 TORONTO A6 M6A 3B6
Business Address 970 LAWRENCE AVENUE WEST SUITE 904 TORONTO A6 M6A 3B6 (416) 818-7253
Aperture Healthcare Ventures Ltd. (Reporting) CIK: 0002000037 (see all company filings)

State of Incorp.: A6 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41964 | Film No.: 24645538